The Observational Medical Outcomes Partnership (OMOP) is a public-private partnership designed to inform the appropriate use of observational data for studying the real-world effects of medical products. OMOP is a multi-year methodological research initiative that has developed a network of administrative claims and electronic health records databases and established a community of methodologists to test the feasibility and utility of large-scale observational analyses. Each year, OMOP holds an annual symposium to publicly share insights from the partnership's ongoing research with all interested stakeholders.
Moderator:
William DuMouchel, PhD, OMOP Research Investigator
Chief Statistical Scientist, Oracle Health Sciences
Panelists:
Stephen Evans BA MSc C Stat FRCP (Edin) FISPE, Professor of Pharmacoepidemiology, London School of Hygiene & Tropical Medicine
Ralph I. Horwitz, MD, MACP, Senior Vice President for Clinical Evaluation Sciences and
Senior Advisor to the Chairman of Research and Development, GlaxoSmithKline
Stephen P. Spielberg, MD, PhD, Deputy Commissioner for Medical Products and
Tobacco, US Food and Drug Administration
Alexander M. Walker, MD, DrPH, Principal, World Health Information Science
Consultants, LLC
